Dysregulation of Wnt/β‐catenin can induce EMT in ovarian cancer, which is characterized by decreased expression of the epithelial marker, E‐cadherin, and increased levels of mesenchymal markers, such as vimentin (28). This evidence concerns the gene CDH1 and ovarian carcinoma.